Fig. 5
From: The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells

The effects of propofol in combination with cisplatin and doxorubicin on autophagy in human ovarian cells. (A-B) Fluorescence microscopy images of SKOV3 and OVCAR3 cells treated with propofol at concentrations of 0 and 50 µg/ml, and stained with AO, are shown (scale bar: 10 μm). (C-D) SKOV3 and OVCAR3 cells treated with propofol at concentrations of 0, 10, 30, and 50 µg/ml combined with either 10 µM cisplatin or 1 µM doxorubicin for 24 h were analyzed using flow cytometry with AO staining. The bars represent the mean ± SD of three independent experiments. Statistical significance is indicated by * for p < 0.05, ** for p < 0.01, and *** for p < 0.001, determined using Student’s t-tests. Cell lysates of (E) SKOV3 and (F) OVCAR3 were subjected to Western blot analysis using antibodies against the indicated proteins. ACTN was the protein loading control